OR WAIT null SECS
October 14, 2021
SGS is investing in a new E&L lab in Navi Mumbai, India, that will provide testing services.
AION Labs will be a first-of-its-kind AI/pharma and computational biology innovation lab aimed at spearheading the adoption of AI technologies and computational science.
This acquisition grants Bionano access to BioDiscovery’s clinical software solution for variant analysis.
The collaboration between Intellia and SparingVision will work to develop genomic medicines for ocular diseases.
The Pharmaceutical Technology and BioPharm International editors host industry experts, highlighting trends and new technologies.
Avid Bioservices is building a viral vector development and manufacturing facility near its existing biologics manufacturing facility in California.
Enzyvant’s Rethymic is the first FDA approved treatment for congenital athymia.
Element’s acquisition of Nanosyn is the latest in a series of moves made to strengthen the company’s North American presence.
Roche has submitted a marketing authorization application to EMA for Ronapreve (casirivimab/imdevimab) as a treatment for COVID-19.
EMA has halted the rolling review of CureVac's COVID-19 candidate, CVnCoV, due to the company withdrawing from the process.